; and (2) in subsection (b)— (A) in paragraph (4)(A), by striking 2017 through 2021 and inserting 2018 through 2024 ; and (B) in paragraph (5), by striking $20,000,000 for each of fiscal years 2017 through 2021 and inserting $60,000,000 for each of fiscal years 2018 through 2024 . 202. Account for the State and Tribal response to the opioid abuse crisis Section 1003(h) of the 21st Century Cures Act ( 42 U.S.C. 290ee–3 note) is amended by striking $500,000,000 for each of fiscal years 2019 through 2021 and inserting $500,000,000 for fiscal years 2019 and $3,750,000,000 for each of fiscal years 2020 through 2023 . III Expanding Access to Treatment Services 301. Eliminating time limitation for nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, certified nurse midwives, and physician assistants To be qualifying practitioners Section 303(g)(2)(G)(iii)(III) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G)(iii)(III) ) is amended by striking for the period beginning on October 1, 2018, and ending on October 1, 2023, . 302. Coverage of methadone under Medicare part B (a) Coverage Section 1861(s)(2) of the Social Security Act ( 42 U.S.C. 1395x(s)(2) ) is amended— (1) by striking and at the end of subparagraph (GG); (2) by adding and at the end of subparagraph (HH); and (3) by inserting after subparagraph (HH) the following new subparagraph: (II) methadone, if furnished or dispensed (including by prescription) in an oral form on or after January 1, 2019, to an individual for the purpose of maintenance or detoxification treatment by a physician or other practitioner who has in effect a registration or waiver under section 303(g) of such Act ( 21 U.S.C. 823(g) ) to dispense methadone for such purpose